Abstract Background This Obesity Medicine Association (OMA) Clinical Practice Statement
(CPS) is intended to provide clinicians an overview of type 2 diabetes mellitus (T2DM), an …

Background A common adiposopathic complication of obesity is type 2 diabetes mellitus.
Healthful weight reduction in patients with obesity can improve glucose metabolism and …

Abstract Background Roux-En-Y gastric bypass (RYGB) and Sleeve Gastrectomy (SG) have
shown to be two of the most effective interventions to enhance weight loss and associated …

Aim Metabolic and bariatric surgery (MBS) is considered one of the most effective
interventions for weight loss and associated type-2 diabetes mellitus (T2DM) remission …

Abstract Background/Objective There are limited real-world studies assessing semaglutide
weight loss and associated comorbidity and metabolic outcomes over periods≥ 6 months …

Gut microbiota dysbiosis has been reported as a risk factor in the development of type 2
diabetes mellitus (T2DM). Polysaccharides from Phellinus igniarius (P. igniarius) possess …

Gut motility and hormone changes after bariatric procedures : Current Opinion in Endocrinology,
Diabetes and Obesity Gut motility and hormone changes after bariatric procedures : Current …

Artificial sweeteners are sugar substitutes that provide high sweetening power associated
with low accompanied calories. In this study, we aim to review the data on the use, benefits …

Aim The action to control cardiovascular risk in diabetes (ACCORD) trial showed a neutral
average treatment effect of intensive blood glucose and blood pressure (BP) controls in …

Aims To compare weight loss outcomes between patients starting semaglutide who had
previously been on another anti‐obesity medication (AOM) compared to those who were …